Anti-aging pill tested in 1-year human trial

NCT ID NCT06592859

Recruiting now Disease control Sponsor: People's Hospital of Quzhou Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests whether taking a daily capsule of nicotinamide mononucleotide (NMN) can reduce biological age in healthy adults aged 40-70. Over 240 participants will take either NMN or a placebo for one year. Researchers will measure aging using blood tests and other markers to see if NMN can truly slow the aging process.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: nicotinamide mononucleotide (NMN) dietary supplement
What this could lead to: If it works, this could point toward a simple supplement to slow or reverse some signs of aging in healthy people.
What could go wrong: This is an early-stage study with only 240 participants, so results may not apply to everyone. NMN supplements are not regulated like drugs, and long-term safety is unknown.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for AGING are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

AGING NMN

Contacts and locations

Locations

People's Hospital of Quzhou
RECRUITING

Quzhou, Zhejiang, 324000, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.